Skip to main content
. 2017 Jul 10;21:176. doi: 10.1186/s13054-017-1763-5

Table 1.

Demographic and clinical characteristics of patients with candidaemia and bacteraemia at the time of infection

Variable Candidaemia* (n = 73, 44%) Bacteraemia** (n = 93, 56%) P
Demographic variables
 Age, years (median (IQR)) 64 (52–76) 67 (48–73) 0.439
 Male gender 43 (59) 54 (58) 0.913
Clinical variables
 Type of patient 0.502
  Surgical 28 (38) 31 (33)
  Medical 45 (62) 62 (67)
 Previous abdominal surgery 13 (18) 16 (17) 0.919
 Chronic renal failure 19 (26) 23 (25) 0.849
 Diabetes mellitus 14 (19) 20 (22) 0.712
 Charlson score (median (IQR)) 3 (2-4) 2 (2-5) 0.546
 Presence of CVC 60 (82) 60 (65) 0.012
 Haemodialysis 7 (10) 13 (14) 0.389
 Receipt of albumin 6 (8) 17 (18) 0.073
 Receipt of immunoglobulins 0 (0) 2 (2) 0.504
 Corticosteroid therapy 15 (21) 17 (18) 0.713
 Previous antibiotics 64 (88) 46 (49) <0.001
 Previous antifungals 12 (16) 8 (9) 0.124
Candida colonization 21 (29) 23 (25) 0.599
 Time from admission to candidaemia or bacteraemia, days (median (IQR)) 21 (10–46) 14 (8–29) <0.001

Values are shown as n (%) unless otherwise indicated

* Candida albicans (n = 37), Candida parapsilosis (n = 23), Candida tropicalis (n = 7), Candida glabrata (n = 4), Candida guilliermondii (n = 1), Candida lusitaniae (n = 1)

** Klebsiella spp. (n = 23), Staphylococcus aureus (n = 12), Escherichia coli (n = 11), Pseudomonas aeruginosa (n = 11), coagulase-negative staphylococci (n = 8), Enterococcus spp. (n =5), Enterobacter spp. (n = 4), Proteus spp. (n = 4), Serratia spp. (n = 3), Acinetobacter spp. (n = 2), Streptococcus spp. (n = 2), Citrobacter spp. (n = 1), Providencia spp. (n = 1), Pseudomonas aeruginosa + Staphylococcus aureus (n = 1), Acinetobacter spp. + Pseudomonas aeruginosa (n = 1), Acinetobacter spp. + Staphylococcus aureus (n = 1), Enterococcus spp. + Klebsiella spp. (n = 1), Escherichia coli + Klebsiella spp. (n = 1), Escherichia coli + Pseudomonas aeruginosa (n = 1)

CVC central venous catheter, IQR interquartile range